Shiratsuki S.; Terai S.; Murata Y.; Takami T.; Yamamoto N.; Fujisawa K.; Burganova G.; Quintanilha L.; Sakaida I.
(2016)
© 2015 John Wiley & Sons, Ltd. Aim: Less invasive therapies using mesenchymal stem cells (MSC) are being developed to treat patients with severe liver cirrhosis. MSC constitute a promising cell source for regenerative ...